J.B. Chemicals and Pharmaceuticals Limited, established in 1976, is one of India's leading pharmaceutical companies. An integrated, publicly-listed organization with a focus
JB Chemicals & Pharmaceuticals Limited
-(JBCHEPHARM)
XNSE:JBCHEPHARM, XBOM:JBCHEPHARM
J B Chemicals & Pharmaceuticals Ltd Q4FY24; 43% rise in Profits
J.B. Chemicals and Pharmaceuticals Limited, established in 1976, is one of India's leading pharmaceutical companies. An integrated, publicly-listed organization with a focus
J B Chemicals & Pharmaceuticals Ltd Q1FY24; 35% rise in Profits
J.B. Chemicals and Pharmaceuticals Limited, established in 1976, is one of India's leading pharmaceutical companies. An integrated, publicly-listed organization with a focus
JB Chemicals & Pharmaceuticals Limited (JBCHEPHARM) Q4 FY23 Earnings Concall Transcript
JB Chemicals & Pharmaceuticals Limited (NSE: JBCHEPHARM) Q4 FY23 Earnings Concall dated May. 25, 2023. Corporate Participants: Jason D'Souza -- Vice President,
Earnings Summary Of J.B. Chemicals & Pharmaceuticals Limited For Q4 FY23
J.B. Chemicals & Pharmaceuticals Limited is a leading pharmaceutical company based in India. With a rich heritage of over four decades, the
Earnings Summary Of J.B. Chemicals & Pharmaceuticals Limited For Q3 FY23
J.B. Chemicals & Pharmaceuticals (NSE: JBCHEPHARM) has a diversified product portfolio that covers various therapeutic areas such as cardiology, dermatology, gastroenterology, neurology,
JB Chemicals & Pharmaceuticals Limited (JBCHEPHARM) Q3 FY23 Earnings Concall Transcript
JB Chemicals & Pharmaceuticals Limited (NSE:JBCHEPHARM) Q3 FY23 Earnings Concall dated Feb. 09, 2023. Corporate Participants: Jason D'Souza -- Vice President, Investor Relations Nikhil
JB Chemicals & Pharmaceuticals Limited Q2 FY23 Earnings Conference Call Insights
Key highlights from JB Chemicals & Pharmaceuticals Limited (JBCHEPHARM) Q2 FY23 Earnings Concall Management Update: [00:06:28] JBCHEPHARM said that in domestic markets
JB Chemicals & Pharmaceuticals Limited (JBCHEPHARM) Q2 FY23 Earnings Concall Transcript
JB Chemicals & Pharmaceuticals Limited (NSE:JBCHEPHARM) Q2 FY23 Earnings Concall dated Nov. 14, 2022 Corporate Participants: Jason D'Souza -- Vice President of Investor Relations Nikhil Chopra -- Chief
JB Chemicals & Pharmaceuticals Limited Q1 FY23 Earnings Conference Call Insights
Key highlights from JB Chemicals & Pharmaceuticals Limited (JBCHEPHARM) Q1 FY23 Earnings Concall Q&A Highlights: Rahul Jeewani from IIFL Securities asked about
JB Chemicals & Pharmaceuticals Limited Q3 FY22 Earnings Conference Call Insights
https://www.youtube.com/watch?v=HiVTF6vv9q0 Key highlights from JB Chemicals & Pharmaceuticals Limited (JBCHEPHARM) Q3 FY22 Earnings Concall Management Update: The company outperformed the sector with